إعلان
إعلان
AGIO
Agios Pharmaceuticals, Inc.
28.41
USDبرعاية
+0.25
+0.89%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
28.41
0.00
0.00%
تقارير أرباح AGIO
النسبة الإيجابية المفاجئة
AGIO تفوق 26 من 39 آخر التقديرات.
67%
التقرير التالي
بيانات التقرير القادم
١١ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$12.38M
/-$1.99
التغير الضمني من Q3 25 (Revenue/ EPS)
-3.89%
/+11.80%
التغير الضمني من Q4 24 (Revenue/ EPS)
+15.36%
/+38.19%
Agios Pharmaceuticals, Inc. earnings per share and revenue
On ٣٠ أكتوبر ٢٠٢٥, AGIO reported earnings of -1.78 USD per share (EPS) for Q3 25, beating the estimate of -1.93 USD, resulting in a 8.09% surprise. Revenue reached 12.88 مليون, compared to an expected 10.63 مليون, with a 21.22% difference. The market reacted with a +2.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 المحللين forecast an EPS of -1.99 USD, with revenue projected to reach 12.38 مليون USD, implying an زيادة of 11.80% EPS, and نقصان of -3.89% in Revenue from the last quarter.
الأسئلة الشائعة
What were Agios Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Agios Pharmaceuticals, Inc. reported EPS of -$1.78, beating estimates by 8.09%, and revenue of $12.88M, 21.22% above expectations.
How did the market react to Agios Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 2.91%, changed from $41.96 before the earnings release to $43.18 the day after.
When is Agios Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for ١١ فبراير ٢٠٢٦.
What are the forecasts for Agios Pharmaceuticals, Inc.'s next earnings report?
Based on 12
المحللين, Agios Pharmaceuticals, Inc. is expected to report EPS of -$1.99 and revenue of $12.38M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان